XORTX Therapeutics Debt to Equity Ratio Analysis

XORTX Therapeutics Inc (XRTX)

1.32 +0.02 (+1.54%) USD | NASDAQ | Nov 14, 16:00

1.32 0.00 (0.00%) After-Hours: 17:39

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to . Upgrade now.

Date	Value

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

Aurinia Pharmaceuticals Inc	0.00
Edesa Biotech Inc	--
Lexaria Bioscience Corp	0.00
Xenon Pharmaceuticals Inc	--
ESSA Pharma Inc	--

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	4.799M
Total Liabilities (Quarterly)	2.095M
Shareholders Equity (Quarterly)	2.705M